Alternatives to Chemik

Physics-based software platform for molecular discovery and design in life and materials sciences.

Atomwise uses AI to accelerate the discovery of novel small molecule therapeutics with its AtomNet platform.

Vivodyne is developing advanced AI models for drug discovery and development.

AI-powered research assistant for scientific literature review and data extraction.

Quantum software company enabling breakthroughs in chemistry, materials science, and life sciences.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Developing oral small molecule medicines for immunological and chronic diseases.

Platform to accelerate scientific discovery using AI.

AI-powered molecular simulation for accelerating drug discovery and materials science.

Developing infrared analysis technology for nanoscale materials.

AI-driven evolutionary design for industrial processes, optimizing efficiency and sustainability.

Phylaro is a company focused on developing AI-powered solutions for scientific research and discovery.

AI platform for drug discovery and development, accelerating research and clinical trials.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

AI-powered customer service platform for seamless human-AI collaboration.

AI-powered drug discovery platform for accelerated molecular design.

Manufacturing advanced silicon-carbon composite anode materials for lithium-ion batteries.

AI-driven drug discovery spinoff from DeepMind using AlphaFold to discover novel medicines.

Formlabs designs and manufactures professional 3D printers and materials, making digital fabrication accessible for engineers, designers, and manufacturers.

Develops a computational model of the human body for drug discovery and development.

Biotechnology company developing and commercializing cell therapies for cancer treatment.

A global oncology company developing and commercializing innovative cancer treatments.

Enabling pharmaceutical companies to deliver medications directly to patients at scale.

A public benefit company focused on quantum-safe security and AI.

Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.

Developing a novel process to produce low-carbon cement.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

Connects patients, providers, pharmacies, and life science companies to improve treatment affordability.

Developing novel therapeutics to restore gut lymphatic function.

Multimodal foundation models that impute missing patient biology data for clinical trial selection.

Developing flexible, efficient, and low-cost solar cells to turn any surface into an energy source.

Magnus Metal offers Digital Casting™ technology, a digital, Industry 4.0 solution for metal casting.

Leveraging quantum mechanics for accelerated molecular simulations in drug discovery.

Revolutionizing battery recycling for a circular future in Europe.

Notpla develops and produces sustainable, plastic-free packaging solutions from seaweed and plants, offering biodegradable and compostable alternatives for various applications.

Pasqal develops quantum computing solutions for complex scientific and industrial problems.

Real-time analytics database for building data-intensive applications.

Develops non-flammable, high-performance, low-cost sodium-ion batteries for energy storage.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

Leveraging AI and a massive patient tissue dataset to accelerate drug discovery and advance precision medicine.

Quantum sensing microscope for nanoscale magnetic imaging and material analysis.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

Designs, develops, and manufactures gallium nitride on silicon carbide (GaN-on-SiC) epitaxial wafers using proprietary growth technologies.

Enzyme-based technology to break down alcohol in the stomach.

Designs and manufactures advanced cryogenic I/O infrastructure for quantum computers.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Biopharmaceutical company developing and commercializing CNS disease treatments.

A global leader in clinical pharmacology and bioanalytical sciences.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Quantum computing application and algorithm development

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.